Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian M. Salata
Cost-Effectiveness of Dabigatran (150 Mg Twice Daily) and Warfarin in Patients ≥65 Years With Nonvalvular Atrial Fibrillation
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Related publications
Practical Guide to Choosing Dabigatran 150 Mg Twice Daily or Apixaban 5 Mg Twice Daily for Patients With Atrial Fibrillation
Journal of Rural Medicine
Cost-Effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
Archives of Internal Medicine
Cost-Effectiveness Analysis of Apixaban Against Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation in Japan
Clinical Therapeutics
Pharmacology
Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation
Yearbook of Cardiology
Effectiveness and Safety of 110 or 150 Mg Dabigatran Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation.
British Journal of Clinical Pharmacology
Pharmacology
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin
Archives of Internal Medicine
Comparative Effectiveness and Safety of Warfarin and Dabigatran in Patients With Non-Valvular Atrial Fibrillation in Japan: A Claims Database Analysis
Journal of Cardiology
Cardiovascular Medicine
Cardiology
